← All trials
NCT04274270
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2020
- Primary completion
- Jan 30, 2022
- Completion date
- Jan 30, 2023
- First posted
- Feb 18, 2020
- Last posted
- Feb 18, 2020
- Enrollment
- 60
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Peking UniversityLead sponsor
- Shanxi Medical UniversityCollaborator
- Xuzhou Medical UniversityCollaborator
- Guangxi Medical UniversityCollaborator
- Chinese Academy of Medical SciencesCollaborator
- Peking UniversityCollaborator
- Mianyang Central HospitalCollaborator
- People's Liberation Army of ChinaCollaborator
- Dalian Medical UniversityCollaborator
- Liaohe Oil Field General HospitalCollaborator
- Hiser Medical Center of QingdaoCollaborator
- Guizhou Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.